(13-138) Evaluation of Oral Factor Xa Inhibitors in Patients with Atrial Fibrillation and for Venous Thromboembolism Prevention and Treatment

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: CHRISTUS Mother Frances Hospital-Tyler (Amb Care Service)
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Texas

Co-Author(s): Elizabeth A. Peck, Alyssa Proctor

Primary Author(s)

Reeth K. Pooni, PharmD

Pharmacist Resident
CHRISTUS Trinity Mother Francis Health System